Defects in assembly are suggested to signal the dissociation of faulty splicing complexes. A yeast genetic screen was performed to identify components of the putative discard pathway. Weak mutant alleles of SPP382 (also called NTR1) were found to suppress defects in two proteins required for spliceosome activation, Prp38p and Prp8p. Spp382p is shown necessary for cellular splicing, with premRNA and, for some alleles, excised intron, accumulating after inactivation. Like spp382-1, a mutant allele of AAR2 was identified in this suppressor screen. Like Spp382p, Aar2p has a reported role in spliceosome recycling and is found with Spp382p in a complex recovered with a mutant version of the spliceosomal core protein Prp8p. Possible insight into to the spp382 suppressor phenotype is provided by the observation that defective splicing complexes lacking the 5 exon cleavage intermediate are recovered by a tandem affinity purification-tagged Spp382 derivative. Stringent proteomic and two-hybrid analyses show that Spp382p also interacts with Cwc23p, a DNA J-like protein present in the spliceosome and copurified with the Prp43p DExD͞H-box ATPase. Spp382p binds Prp43p and Prp43p requires Spp382p for intron release from the spliceosome. Consistent with a related function in the removal of defective complexes, three prp43 mutants are also shown to suppress splicing defects, with efficiencies inversely proportionate to the measured ATPase activities. These and related genetic data support the existence of a Spp382p-dependent turnover pathway acting on defective spliceosomes.
S
pliceosome assembly in Saccharomyces cerevisiae (yeast) extract progresses through the sequential addition of the U1, U2, and U4͞U6.U5 small nuclear ribonucleoprotein (snRNP) particles. The snRNP-complete complex then undergoes conformational changes to form a catalytically active enzyme (reviewed in refs. 1 and 2). In this hallmark activation step, the extensively paired U4͞U6 snRNAs unwind, and the U6 snRNA displaces U1 at the 5Ј splice site and associates with the branchpoint region through U2 snRNA contacts. The U1 and U4 snRNAs dissociate from (or more weakly bind) the mature spliceosome, and neither is required for catalysis. Although alternate models have been proposed e.g., ref. 3 , the isolation of cellular U2, U5, and U6 snRNP complexes (4, 5) strongly supports an equivalent spliceosome maturation pathway in vivo. This view is reinforced by studies of cotranscriptional premRNA splicing that reveal striking similarities in the timing of splicing factor association in vivo and in vitro (6, 7) .
The specificity determinants for U4͞U6.U5 tri-snRNP recruitment to the prespliceosome are unclear, although U5 snRNP-exon interactions and transient U4 and U6 snRNA contacts with the premRNA 5Ј splice site region may contribute (1, 8, 9) . Once bound, the U5 snRNP-associated Prp28p and Brr2p DExD͞H-box proteins are critical for U1 and U4 snRNP release from the spliceosome, respectively (10) (11) (12) (13) . Other spliceosomal proteins clearly function in this activation step because, for instance, certain mutant alleles of PRP4, PRP38, and SNU114 form snRNP-complete, but catalytically impaired, spliceosomes (14) (15) (16) (17) . Also, reflecting the pivotal role of Prp8p in active site assembly, certain prp8 mutant alleles suppress growth defects because of prp28 or brr2 mutation or resulting from U4͞U6 snRNA hyperstabilization (16, 18, 19) . Soon after U4 snRNA release, a set of 8-12 proteins, the nineteen complex, tightly binds the spliceosome (20) and stabilizes association of select tri-snRNP recruited factors (4, 21) . Subsequently, other DExD͞ H-box proteins promote conformational changes needed for the first RNA transesterification reaction (Prp2p), the second transesterification reaction (Prp16p, Prp22), mRNA release (Prp22p), and intron release (Prp43p) (1) .
Surprising little is known of how spliceosomal DExD͞H proteins are recruited, what governs the temporal restriction of activities, or even the principal targets of ATP-dependent function (e.g., RNA unwinding or protein displacement). In contrast, the spliceosome assembly defects associated with the loss of each activity are well established, and, over a decade ago, Burgess and Guthrie proposed a model in which splicing fidelity is coupled to ATP hydrolysis by the Prp16 DExD͞H-box protein (22) (23) (24) . Key to this ''kinetic proofreading'' mechanism is the existence of a discard pathway to remove defective complexes. Although the components are unknown, such a discard pathway is speculated to act throughout the spliceosome cycle as a quality control system for complex integrity (2).
Here we report the results of a genetic study to identify components of the spliceosome discard pathway. The prp38-1 mutation causes a temperature sensitive (ts) growth defect because of impaired premRNA splicing (25) that, in vitro, results from slow release the U1 and U4 snRNAs (15) . We reasoned that the prp38-1 defect might be relieved by extragenic suppressors that directly enhance splicing efficiency or, alternatively, reduce the turnover of kinetically impaired spliceosomes. Mutant alleles of SPP382 are shown to suppress both prp38-1 and prp8-1 growth defects. Spp382p itself is necessary for splicing and efficient intron metabolism, however, with premRNA and excised intron accumulating after inactivation. Spp382p was previously reported as Ccf8p, a protein implicated in spliceosome dynamics (4) and as Ntr1p, a required factor for Prp43-dependent intron release in vitro (26) (henceforth called by its Saccharomyces Genome Database standard name, SPP382). Consistent with PRP43 involvement the proposed discard pathway, prp43 mutants also suppress splicing defects, intriguingly, with efficiencies inversely proportional to the measured ATPase activity. Finally, a mutant in AAR2 that encodes a spliceosome recycling factor biochemically linked with Spp382p likewise acts as a prp38-1 suppressor. A possible clue to the spp382 suppressor activity comes from the observation that, in vitro, defective lariat intermediate complexes, lacking the upstream (5Ј) exon, are specifically recovered with Spp382-Tap. These and related studies support a role for the Spp382p-Prp43p intron release complex in the turnover of defective spliceosomes.
Results
Extragenic Suppression of a Spliceosome Activation Mutant. Spontaneous suppressors of the ts prp38-1 ts mutation were selected on rich medium at 37°C. Two suppressors unlinked to PRP38 or to the previously identified dosage suppressor, SPP381 (27) , were identified. One results from a D281N substitution in the established splicing factor (28), Aar2p (Fig. 1B) , whereas the second resided within the then-uncharacterized gene we called spp382-1, for the second suppressor of prp38-1 (Fig. 1 A) . Because spp382-1 is recessive, the wild-type SPP382 allele was recovered by screening genomic DNA library transformants for the reacquisition of temperature sensitivity. Linkage analysis shows that orf YLR424W is inseparable from the suppressor locus and thus defines SPP382. Plasmid-based SPP382 expression inhibits growth in the prp38-1, spp382-1 (suppressor) background but does not alter the growth of either wild-type yeast or the ts prp38-1 mutant in the absence of spp382-1 (Fig. 1 A;  pSPP382 ). (Fig. 1C) . Western analysis identifies Spp382p as Ccf8p, a protein copurified with the Clf1p nineteen complex protein (Ccf8p; S.P., Q. Wang, and B.C.R., unpublished data) (4). Spp382-1p differs from wild type by a L232P substitution downstream of this G-patch. SPP382 is required for yeast viability (31) , but a cellular function in splicing has not been demonstrated. To investigate this possibility, we tested a series of site-directed mutations in regions of high conservation between the yeast, human, zebrafish, fruit fly, and nematode homologs for biological activity.
The plasmid-based mutant alleles were assayed for complementation of a lethal spp382::KAN disruption after plasmid shuffle to remove a functional GAL1::SPP382 gene. A double G-patch substitution (spp382-9) and a more complex G-patch alteration (spp382-10) proved lethal ( Fig. 1C and Table 1 ), consistent with this being an essential Spp382p motif. Two single amino acid changes within the G-patch (spp382-2 and spp382-3) were viable but showed impaired growth, especially at lower temperatures, whereas a nine-codon deletion within a central domain (spp382-5) is tightly ts above 30°C. Two mutants with triple alanine substitutions near the C terminus (i.e., spp382-7 and spp382-8) grow similar to wild type, whereas a nearby frameshift mutation (spp382-6) results in slow growth. Finally, an N-terminal deletion that shifts translational initiation to codon 34 (spp383-4), supports nearly normal growth when expressed from the GAL1 promoter.
We next scored the mutant set for prp38-1 suppression (Table  1) . Relative suppressor activity was difficult to quantify because the spp382 mutations alone cause variable degrees of growth inhibition. Also, we note that spp382-1-based suppression is less robust when expressed from the plasmid, possibly because of differences in gene expression. Nevertheless, suppressor alleles were found distributed throughout the coding sequence (i.e., spp382-1, spp382-4, spp382-6, and spp382-8), whereas one mutant, the tight ts allele spp382-5, was lethal in the prp38-1 background. None of the mutations suppressed a lethal prp38::KAN null allele and, similarly, the prp38-1 mutation did not rescue the lethality of the spp382-9 or spp382-10 (data not shown). The simplest interpretation of these observations is that Spp382p is an essential protein which, when limiting, suppresses prp38-1. 23C 37C shown). For the other site-directed mutants, the level of splicing correlates well with the growth observed ( Fig. 2B and data not shown). Mutants that support robust growth show little splicing inhibition (e.g., spp382-7 and spp382-8), whereas those with significant growth defects (spp382-1, spp382-2, spp382-3, spp382-5, and spp382-6) show considerable splicing impairment, typically worse at the elevated temperature. spp382-7 shows no growth or splicing defects and does not suppress prp38-1. Thus, although dispensable for splicing in vitro (26), Spp382p is essential for first transesterification step in vivo.
Although not apparent with RPS17A or RPL28 probes ( Fig. 2 A-C and data not shown), splicing is inhibited and excised intron accumulates with several of the spp382 alleles when ACT1 is monitored ( Fig. 2B and data not shown). The relative intron levels do not precisely correlate with apparent splicing inhibition or prp38-1 suppression, however. Intron accumulation is greatest with central domain mutants (spp382-1 and spp382-5, the latter independent of assay temperature) and with one of the G-patch mutants (spp382-3) when assayed at room temperature. Consistent with previous reports (32, 33) , this same RNA species accumulates after removal of the Dbr1p 2Ј-5Ј debranching activity or Prp43p (Q. Wang and B.C.R., unpublished data). Finally, we note that splicing enhancement is very subtle in the suppressor strain background when assayed with either RPS17A or RPL28, indicating that neither ribosomal protein is likely limiting for growth under these conditions (Fig. 2C and data (Fig. 3A) . When compared with the input RNA, the recovery of excised intron is favored, especially late in the splicing reaction. Lariat intermediate and excised intron are also recovered, albeit more efficiently, with Prp19-TAP. For both, premRNA, but little or no spliced mRNA, is present in the IgG pellets. As a specificity control, a minor amount of premRNA, but no lariat intermediate or excised intron is recovered with a tagged branchpoint binding protein (BBP-TAP). BBP binds early and transiently to the splicing apparatus, consistent with premRNA signals decreasing to background (WT, no tag) late in the reaction.
Unlike Prp19-TAP, little or no 5Ј exon signal is detected in the Spp382-TAP IgG pellet, even with a four-fold increase in exposure time (Fig. 3A , compare lanes 16-18 and 28-30) . Qualitatively equivalent results were obtained with the ACT1 premRNA (data not shown). Trace levels of excised intron but no ''5Ј exonless'' intermediates were reported associated with Spp382p in an earlier study (26) , although the late-stage reactions used would make such an evaluation problematic. To further investigate this issue, we used an RNA substrate truncated just upstream of the 3Ј splice site (⌬3ЈSS; Fig. 3B ) for which the lariat intermediate and free exon are terminal products. Nonspecific RNA binding to the resin is negligible (lanes 11 and 12). As with the full-length substrate, lariat intermediate and 5Ј exon are recovered from the 30-min splicing reaction with Prp19-TAP in amounts that approximate the 2.5:1 signal ratio expected based on nucleotide content (lanes 9 and 10). With Spp382p, greater levels of lariat intermediate are recovered relative to the full-length RNA, although the relative premRNA recovery did not change. As before, little or no free 5Ј exon is found in the IgG pellet (lanes 1 and 2). The trivial possibility that IgG selection causes release of the upstream exon appears unlikely as free (i.e., nonspliceosomal) 5Ј exon is resolved by glycerol gradient fractionation before selection (see Supporting Text and Fig. 5 , which are published as supporting information on the PNAS web site). Here, lariat intermediate molecules are preferentially recovered from lighter, possibly incomplete, spliceosomal fractions. Evidence for spontaneous 5Ј exon release from in vitro assembled spliceosomes traces back to the origins of this field (e.g., see gradient image in ref. 34 ). We estimate that under these conditions the 5Ј exonless complexes represent Table 1 . Growth assays performed in yeast with the indicated SPP382 allele at 23°C and at 37°C
The symbols reflect relative colony sizes from wild-type (ϩϩϩ) to no growth (Ϫ). Visible colonies from an otherwise inviable prp38 -1mutant were indicative of suppression (Yes), whereas no growth indicates lack of suppression (No). NA, not applicable; Syn. lethal, synthetic lethality. *This allele was expressed with the GAL1 promoter. All other alleles were expressed with the natural SPP382 promoter. Ϸ15% of the lariat intermediate pool with this truncated RNA, more than twice that found with the full-length RNA substrate. Compared with Prp19-TAP, less premRNA is recovered with a BBP-TAP and Spp382-TAP (Fig. 3B, compare lanes 2, 4 , and 10 with lane 12). Consistent with specific association, however, premRNA recovery is enhanced (and splicing blocked) when the BBP-TAP commitment complex is stabilized by oligonucleotidedirected RNase H digestion of U2 snRNA (compare lanes 4 and 6 in the lower exposure detail). No change is observed when a control oligonucleotide is used (lane 8). In addition, the prem-RNA recovered with Spp382-TAP exclusively comes from the spliceosomal 40-50S fractions even though most of the prem-RNA remains in the unassembled pool (see Fig. 5 ).
The data presented above suggests that Spp382p may bind weakly or transiently to a subset of spliceosomal complexes, most surprisingly, defective spliceosomes from which the 5Ј exon has been lost. To investigate the role of the upstream exon in sample recovery, we repeated the splicing reactions with RPS17A substrates where the 38 nucleotide 5Ј exon was lengthened (ϩ13) or shortened by 16 or 25 nucleotides (Fig. 3C) . As measured by phosphoimaging, the lariat intermediate to fully excised intron (L͞I) ratio, an inverse measure of step two splicing efficiency, increases Ϸ1.2-fold between the shortest and longest substrates (lanes 1-4) . In contrast, this ratio more than doubles in the Spp382-TAP-selected pool (lanes 5-8). This greater than proportionate increase reinforces the belief that a distinct subset of lariat intermediates, specifically the defective complexes, are being selected by Spp382-TAP. The number of complexes from which the 5Ј exon is lost might increase through stochastic dissociation when the second step of splicing is eliminated (by removal of the downstream exon) or in response to a suboptimal exon sequence (i.e., the truncated 5Ј exon). Although the biological relevance of such defective complexes is yet to be established, evidence from Hillern and Parker (35) suggests that splicing complexes containing the lariat intermediate are targets for turnover in vivo.
Spp382p Interactions with the Cwc23p J-Domain Protein and the
Prp43p ATPase. At low salt concentrations, Spp382p is found in the penta-snRNP (3), the U2, U5, U6 spliceosomal complex (4), and other assemblages of splicing factors, often including Prp43p (36) (37) (38) . As the complexity of these structures limits inference about primary associations, we repurified Spp382-TAP at high stringency (i.e., 450 mM of NaCl) and assayed for protein association by mass spectroscopy. A single splicing-relevant protein, Cwc23p, was found with high confidence (Table 2) . Although the two ribosomal proteins and the 2-m circle-associated Rep2p present are likely contaminants, the Cwc23p-Spp382p association has been confirmed as a reciprocal two-hybrid interaction (Table 2 ; and see Fig.  6 , which is published as supporting information on the PNAS web site).
Cwc23p was previously recovered with Prp43p (37), a protein that both binds Spp382p and is dependent on Spp382p for intron release in vitro (26) . In further support of a Spp382p-Prp43p connection, we find that the prp43R424A mutation (39) is synthetically lethal with spp382-4 and spp382-6 alleles (data not shown). These observations raise the interesting possibility that the suppression of splicing defects by spp382 mutants occurs through impairment of Prp43p function. For such a suppression mechanism to work, however, Prp38-1p defective spliceosomes must retain partial activity at the restrictive temperature. In agreement, simple overexpression of prp38-1 with the GAL1 promoter relieves the ts 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 T P T T T T T P P P P P W T S p p 3 8 2 -T A P B B P -T A P B B P -T A P -c o n t . P r p 1 9 -T A P B B P -T A P α U 2 growth defect almost as well as the established SPP381 dosage suppressor (27) (Fig. 4A) . Another prediction of this model is that spp382-based suppression should not be restricted to PRP38 mutations. Indeed, we find that the ts prp8-1 mutant is also suppressed by the spp382-1, GAL1::spp382-4, and spp382-6 suppressor alleles, although no suppression is observed with a second, arbitrarily selected splicing mutant, prp4-1 (Fig. 4B and data not shown) .
To further probe Prp43p involvement, we assayed three viable prp43 mutants with successively lower ATPase activities for suppression of prp38-1. As predicted by the model of Prp43p-remodeling, each prp43 mutant suppresses prp38-1 and, remarkably, the degree of suppression is inversely related to the reported ATPase activity (39) . And whereas diminished Prp43p activity suppresses prp38-1, overexpression of several other yeast genes, including PRP43, CWC23, and the YNL224C-encoded protein previously purified with Prp43p (37) (that we call SQS1 for squelch of splicing suppression) impairs spp382-1-based suppression (data not shown). Although several explanations for this phenotype are conceivable, the gene-dosage effect is consistent with compensation for reduced Spp382-1p activity by enhanced levels of its associated factors.
Discussion
Under normal circumstances, conformational changes coincident with mRNA formation stimulate Spp382p-dependent Prp43p recruitment or activation resulting in intron release and spliceosome dissociation in vitro (26) . In support of a similar cellular role, we find that, analogous to prp43 mutants, certain mutant alleles of spp382 accumulate excised intron. These alleles include a G-patch mutation within the N-terminal domain that mediates a Prp43p-Spp382p two-hybrid interaction (26, 40, 41) and copurification (38) . Although alternative models are conceivable for how reduced spp382 activity might suppress splicing defects, we favor one based on this established function of Spp382p in complex dissociation. We propose that defects in the splicing complex assembly, for instance because of prp38-1 or prp8-1, promote Spp382p-dependent dissociation of the defective spliceosome through Prp43p. Bolstering this model, we find that spp382 and prp43 mutants are synthetically lethal and that Prp43p overexpression is sufficient to impair spp382-1-based suppression of prp38-1. Finally, and most importantly, we find that PRP43 mutations with reduced ATPase activity also suppress splicing defects.
In addition to spp382-1, aar2G841A was found as a spontaneous suppressor of prp38-1. Aar2p, together with Prp8p, Snu114p, and the core SM proteins, comprise the16S U5 snRNP particle that copurifies with U1 snRNP and is postulated to act in 5Ј splice site recognition (see ref. 28 and references within). The Beggs laboratory (42) recently identified both Aar2p and Spp382p complexed with a mutant version of Prp8p, a protein that binds the 5Ј exon before lariat formation (43, 44) and likely assists in its retention afterward (see ref. 45 ). The defective lariat intermediate recovered with Spp382-TAP might result from modest TAP-based interference with 5Ј exon retention or enhanced Spp382-TAP association with (or epitope accessibility within) a defective spliceosome. Notably, Aar2p, like Prp43p and Spp382p, all serve to recycle splicing factors in vitro (26, 28, 32) . Spliceosomes must function through multiple rounds of catalysis and it is therefore not surprising that the sequestration of limiting proteins in postcatalytic or dead-end splicing complexes should have dire consequences. Recycling factors may act in kinetic competition with factors that promote the completion of splicing or be regulated through specific recruitment or activation steps.
The model presented above is supported by the recovery of both properly excised intron and defective lariat intermediate with Spp382-TAP. Also, the sedimentation profile of the released intron complex (39) is comparable with the nineteen complex fractions enriched with Spp382p͞Ccf8p (4), consistent with at least transient association with late splicing complexes. Indeed, given its size and function in intron release, Spp382p is a prime candidate for the unidentified 80-kDa protein that crosslinks to the branchpoint on completion of splicing (47) . Our two-hybrid and mass spectroscopy analyses do indicate that Spp382p is tightly associated with the spliceosomal DNA J-domain protein, Cwc23p. Given the role of DnaJ(Hsp40)-like proteins in substrate presentation and Hsp70 ATPase activation (48), Cwc23p association is particularly interesting. Should Cwc23p act similarly in spliceosome turnover, possible ATPase partners include Prp43p and two Hsp70 proteins, Ssa2 and Ssa4, implicated in snRNP dynamics (49) and recovered with the spliceosome (ref. 4) . At this point, however, it remains unknown whether all Spp382p-bearing complexes possess Cwc23p or, more generally, how the discard pathway discriminates between defective complexes and authentic spliceosome assembly intermediates.
The spliceosomal DExD͞H-box ATPases drive the spliceosome cycle forward and assures fidelity in splicing when coupled with a discard pathway for the removal of flawed complexes (1, 2, 50) . The results presented here provide strong evidence for a Spp382p-dependent activity acting on impaired spliceosomes, most likely through Prp43p-stimulated dissociation or reorganization. Although candidates for other pathway components are suggested by this study (i.e., Aar2p, Cwc23p, and Sqs1p), it remains to be learned whether Prp43p function in ribosome biogenesis (38, 46) , the turnover of postcatalytic spliceosomes, and the spliceosome integrity activity defined by splicing mutant suppression are accomplished by complexes of equivalent or distinct protein compositions.
Materials and Methods
Yeast Genetics and Plasmid Construction. Spontaneous suppressors of the prp38-1 mutant, ts192 (25) (␣ prp38-1, ura3-52, trp1-289,  leu2-112, 113, and his3) , were selected by growth at 37°C on rich medium (yeast extract͞peptone͞dextrose) (51) . Colonies were backcrossed to the wild-type strain, MGD353-13D (a, trp1-289,  ura3-53, leu2-3,112, arg4, and ade2) , sporulated, and the resultant offspring scored for the reappearance of temperature sensitivity expected for extragenic suppressors. To test for dominance, candidates were mated to the prp38-1 haploid SP101 (a, prp38-1,  ura3-52, trp1-289, leu2-112, 113, his3, and arg4) and the diploid assayed for growth at 37°C. The wild-type SPP382 allele was identified by transforming SP301 (␣ prp38-1, spp382-1 ura3-52,  trp1-289, leu2-112, 113 , and his3) with a centromeric yeast DNA library (52) and screening replica plates of the transformants for temperature sensitivity. A PCR approach was used to subclone SPP382 into vector YCplac33 (53) (primer sequences available on request). Linkage analysis was completed by targeting a URA3-linked copy of SPP382 on plasmid YIpLac211 (53) cleaved with HpaI to its homologous chromosomal locus in strain SPM301. After conformation by Southern blot, the integrant was crossed to wild-type yeast, and the meiotic progeny from 21 tetrads scored for temperature sensitivity.
Inverse PCR with mutagenic oligonucleotides (sequences available on request) and the Expand Long polymerase (Roche Applied Science, Indianapolis, IN) was performed on a YCPlac111 (53) subclone containing the entire SPP382 orf plus 450 bp of 5Ј flanking sequence. The GAL1-derivatives were made similarly with pBM150 (for GAL1::SPP382) (54) and p416 (for GAL1::spp382-4) (55) and expressed in a KAN::spp382 background of BY4742 (obtained from Open Biosystems, Huntsville, AL). All genes were sequenced before use. Yeast cotransformed a YCp111-spp382 mutant allele were assayed after GAL1::SPP382 removal by FOA selection (56) . Suppression of prp8-1 was scored by first mating strain SP302 (a, ura3⌬0, trp1-289, leu2 ⌬0, his3 ⌬1, spp382::KAN, and YCpLac111-spp382-1), SP102 (a, ura3⌬0, trp1-289, leu2 ⌬0, his3 ⌬1, spp382::KAN, and p416-GAL1::spp382-4) or strain SP103 (a, ura3⌬0, trp1-289, leu2 ⌬0, his3 ⌬1, spp382::KAN, and YCpLac111-spp382-6) with JM640 ( a, ade1-1, ade2-1, ura1, tyr1-1, his7, lys2-1,  gal1, and prp8-1) . Suppression of prp4-1 was performed similarly. Double mutant haploid isolates were recovered after sporulation and scored for growth on galactose medium at 23°C, 30°C, 33°C, 35°C, and 37°C. Dosage suppression was performed in strain SPM301 after transformation with a plasmid containing the indicated GAL1-fusion construct (57) . The PRP43-based suppression and synthetic lethality assays were done after crossing the prp43 mutant (␣ ura3-52, trp1-63, his3 ⌬200, leu2-1, ade2-101, ade2-101 , lys2-801, prp43::KAN, p358-prp43, and TRP) with SP101 or the indicated spp382 mutants.
RNA and Protein Analysis. RNA was recovered from yeast and assayed by Northern blot from a 1% agarose͞formaldehyde gel as described (25, 58) . Splicing extracts were prepared under liquid nitrogen in a Spex Certiprep 6850 freezer mill as published (59) with TAP-tagged strains (Open Biosystems). Spp382-TAP was purified by IgG agarose and calmodulin agarose affinity selection using standard procedures (29) with NaCl increased to 450 mM in the binding and wash steps. Two-dimensional liquid chromatography and mass analysis was performed with a Deca mass spectrometer (ThermoElectron, Waltham, MA) as described (4). The mass-intensity lists were screened against the nonredundant National Center for Biotechnology Information protein database with MASCOT software (Matrix Science, Boston, MA) at the default cutoff score of 20. The recovery and analysis of radiolabeled substrate with TAP-tagged proteins was done previously for Clf1-TAP (4).
